Substance Abuse, Intravenous clinical trials
The registry lists 32 studies for Substance Abuse, Intravenous across more than 10 countries. 1 are recruiting or about to start. 15 of them are mainly about Substance Abuse, Intravenous (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-21.
Get an email when these change. Save the Substance Abuse, Intravenous studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Johns Hopkins University (4) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Yale University (2) · Emory University (1) · Lund University (1) · Merck Sharp & Dohme LLC (1) · Indivior Inc. (1) · New York University (1)
What is being tested here
Drugs under test in Substance Abuse, Intravenous studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Buprenorphine | 0 | 0 | 2 |
| Lisdexamfetamine | 0 | 0 | 1 |
| Dalbavancin | 0 | 1 | 1 |
| Sofosbuvir | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Nov 2027A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs · Tampere University Hospital
Who these studies take
Of the 1 Substance Abuse, Intravenous studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 1 (100%) | 1 (100%) |
Across all 32 studies, recruiting or not: 25% stop at 75 or younger and 22% at 65; 6% take children; 6% are for women only and 0% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 32 of 32. search them.
- A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous DrugsRecruitingNCT056792841 country
- Implementing PrEP for Women Who Inject DrugsActive, not recruitingNCT05360849Not applicable1 country
- Break the Cycle: Prevention for Reducing Initiation Into Injection Drug UseCompletedNCT03502525Not applicable2 countries
- Telemedicine and Social Media for People Who Inject Drugs (PWID) in GreeceCompletedNCT057949841 country
- Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient TransitionTerminatedNCT04847921Phase 2/31 country
- Non-Invasive Vagal Nerve Stimulation in Opioid Use DisordersCompletedNCT04556552Phase 31 country
- Change the Cycle: An RCT to Prevent Injection InitiationCompletedNCT02774954Not applicable1 country
- The Long-Term Treatment of Drug Addiction and UnemploymentCompletedNCT02487745Not applicable1 country
- BRIDGE: Improving HIV Service Delivery for People Who Inject DrugsCompletedNCT02796027Not applicable2 countries
- PWID; Longitudinal S Aureus Colonization Pattern and the Impact on Infection Frequency by Regular Showers With ChlorhexidineCompletedNCT03940729Phase 4
- Stage III Community-based Efficacy Trial for Mothering From the Inside OutCompletedNCT02955199Not applicable1 country
- Pre-exposure Prophylaxis (PrEP) for People Who Inject Drugs (PWID)WithdrawnNCT03869671Not applicable
- Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of CareCompletedNCT03093415Phase 41 country
- : Bacterial Infections in Injecting Drug UsersCompletedNCT045507671 country
- Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1CompletedNCT00023283Phase 21 country
- Case Management in HCV Infected PWIDCompletedNCT03106194Not applicable1 country
- Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary CareCompletedNCT004710421 country
- The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network ApproachStatus unknownNCT02363517Phase 31 country
- The Therapeutic Workplace Initiation StudyCompletedNCT00249470Not applicable1 country
- Employment-based Reinforcement of Naltrexone Ingestion and AbstinenceCompletedNCT00149669Not applicable1 country
- A Study of HIV in Newly Infected IndividualsCompletedNCT000009301 country
- Contingency Management in the Delivery of HAART to Drug Users in Chennai, IndiaCompletedNCT01031745Phase 21 country
- Conflict Between Maternal Autonomy and Child Health in Substance-useCompletedNCT027979901 country
- Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution TherapyStatus unknownNCT02638233Phase 41 country
- Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261)CompletedNCT00726557
- Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral TreatmentCompletedNCT00844272Phase 4
- A Randomized Trial of Vaccine Adherence in Young Injection Drug UsersCompletedNCT00244374Not applicable1 country
- Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME")CompletedNCT00955162Phase 41 country
- Reducing Health Problems Associated With Injection Drug UseCompletedNCT01128920Not applicable1 country
- A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk ContactsCompletedNCT00038688Phase 32 countries
- Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse HistoriesCompletedNCT00247572Phase 21 country
- Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, ThailandCompletedNCT00006327Phase 31 country